|
25.05.2023 10:31:50
|
Managers’ transactions
May 25,2023
Announcement no. 32
?
Managers’ transactions?
Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in Pharma Equity Group A/S made by persons discharging managerial responsibilities in Pharma Equity Group and/or persons closely related with them.??
?
| 1. Details of the person discharging managerial responsibilities/person closely associated? | |
a) Name? | Thomas Kaas Selsø |
2. Reason for the notification? | |
a) Position/status? | CEO |
| b) Initial notification/amendment? | Initial notification? |
| 3. Details of the issuer? | |
| a) Name? | Pharma Equity Group A/S? |
| b) LEI? | 2138008SUI4D917FKN20 |
| c) Trade name | PEG |
| 4. Details of the transaction(s)? | |
| a) Description of the financial instrument, type?? of instrument?and Identification code? | Shares, ISIN code DK0061155009 |
| b) Nature of the transaction? | Purchase? |
| c) Price(s) and volume(s)? | Price: DKK 167,225 Volume: 551,724? |
| d) Aggregated information? - Aggregated volume? - Aggregated price? | N/A? |
| e) Date of the transaction? | 25-05-2023, 09:26 CEST |
| f) Place of the transaction? | Nasdaq Copenhagen A/S |
For further information, please contact:?
?
Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14
Peter M. Eriksen, Chair of the Board of Directors of Pharma Equity Group A/S, phone: 51 99 66 00.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pharma Equity Group A-S Registered Shs -Amehr Nachrichten
Analysen zu Pharma Equity Group A-S Registered Shs -Amehr Analysen
Aktien in diesem Artikel
| Pharma Equity Group A-S Registered Shs -A | 0,15 | -0,33% |
|
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.